Finance

Lists
1733:TPE
Apex Biotechnology Corp
30,45 NT$
-0,33%
(-0,100) 1D
8 ოქტ, 13:30:23 GMT+8  ·   TWD
All symbols
SymbolPriceChange% Change
Generating top insights for 1733...
Open
30,55 NT$
High
30,55 NT$
Low
30,30 NT$
Mkt. cap
3,04 მლრდ.
Avg. vol.
114,60 ათ.
Volume
54,32 ათ.
Dividend
4,27%
Quarterly dividend
0,33 NT$
Ex-dividend date
9 ივნ. 2026
P/E ratio
16,12
52-wk high
38,70 NT$
52-wk low
28,00 NT$
EPS
1,89 NT$
Shares outstanding
99,69 მლნ.
No. of employees
641
Open
30,55 NT$
High
30,55 NT$
Low
30,30 NT$
Mkt. cap
3,04 მლრდ.
Avg. vol.
114,60 ათ.
Volume
54,32 ათ.
Dividend
4,27%
Quarterly dividend
0,33 NT$
Ex-dividend date
9 ივნ. 2026
P/E ratio
16,12
52-wk high
38,70 NT$
52-wk low
28,00 NT$
EPS
1,89 NT$
Shares outstanding
99,69 მლნ.
No. of employees
641
News stories
From web sources and news partners
Simply Wall Street
Simply Wall Street
·
1 წუთის წინ
Why Is Nvidia (NVDA) Pushing Deeper Into Open AI And Consumer Devices?
MarketBeat
MarketBeat
·
24 წუთის წინ
BRP (NASDAQ:DOO) Stock Gets Downgrade from Zacks Research
Seeking Alpha
Seeking Alpha
·
4 საათის წინ
S&P 500 Index Concentration - Room At The Top
About Apex Biotechnology Corp
CEO-
Employees641
Founded1997
Headquarters-
SectorMedical device
Previous reportsAll values in TWD
Loading Previous Earnings...
Revenue
Net income
All values in TWD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
437,21 მლნ.
438,99 მლნ.
519,72 მლნ.
470,65 მლნ.
Cost of goods sold
330,39 მლნ.
306,63 მლნ.
344,06 მლნ.
312,37 მლნ.
Cost of revenue
330,39 მლნ.
306,63 მლნ.
344,06 მლნ.
312,37 მლნ.
Research and development expenses
35,94 მლნ.
36,02 მლნ.
37,23 მლნ.
49,84 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
57,27 მლნ.
62,79 მლნ.
60,29 მლნ.
63,81 მლნ.
Operating expense
98,80 მლნ.
99,12 მლნ.
88,45 მლნ.
113,66 მლნ.
Total operating expenses
429,19 მლნ.
405,75 მლნ.
432,51 მლნ.
426,02 მლნ.
Operating income
8,02 მლნ.
33,24 მლნ.
87,21 მლნ.
44,63 მლნ.
Other non operating income
775,00 ათ.
894,00 ათ.
191,00 ათ.
591,00 ათ.
EBT including unusual items
29,21 მლნ.
58,17 მლნ.
86,91 მლნ.
44,68 მლნ.
EBT excluding unusual items
34,02 მლნ.
57,52 მლნ.
90,23 მლნ.
41,45 მლნ.
Income tax expense
7,12 მლნ.
7,97 მლნ.
5,54 მლნ.
7,84 მლნ.
Effective tax rate
24,37%
13,70%
6,38%
17,54%
Other operating expenses
-
-
-
-
Net income
22,14 მლნ.
50,08 მლნ.
81,28 მლნ.
36,78 მლნ.
Net profit margin
5,06%
11,41%
15,64%
7,81%
Earnings per share
-
-
-
-
Interest and investment income
139,00 ათ.
1,49 მლნ.
219,00 ათ.
4,56 მლნ.
Interest expense
-835,00 ათ.
-822,00 ათ.
-829,00 ათ.
-804,00 ათ.
Net interest expenses
-696,00 ათ.
665,00 ათ.
-610,00 ათ.
3,75 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
20,24 მლნ.
45,47 მლნ.
99,16 მლნ.
56,25 მლნ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google აპები